Status:
COMPLETED
The Economic Impact of the Pancreatography in the Endoscopic Treatment of Pancreatic Pseudocysts
Lead Sponsor:
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Conditions:
Pseudocyst Pancreas
Pancreatic Duct Disorder
Eligibility:
All Genders
19+ years
Phase:
NA
Brief Summary
Pancreatic pseudocysts (PP) present as a complication that occurs in 5-15% of acute pancreatitis and 26-40% of chronic pancreatitis (1-3). To date the endoscopic drainage with endoscopic ultrasound (E...
Detailed Description
METHODS: Random control trial between two groups. Group 1 the ERP will be performed the same day of the endoscopic drainage of PP. Group 2 the ERP will be performed 6 weeks after the endoscopic draina...
Eligibility Criteria
Inclusion
- Pancreatic pseudocyst that fulfilled the Atlanta Classification
- Symptomatic pancreatic pseudocyst
- Informed consent obtained
Exclusion
- Patient unwilling to participate
- Absence of duration time of the pancreatography procedure in the record
- Absence of the number of weeks between the drainage and the pancreatography
Key Trial Info
Start Date :
August 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2020
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04494282
Start Date
August 1 2015
End Date
May 1 2020
Last Update
March 6 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.